[HTML][HTML] Rapidly Progressive Dementia: Clue Lies in the Speed of Progression

…, C Rathore, S Kumar, G Yeeli - Journal of Integrated …, 2021 - journals.lww.com
Dementia is one of the most common neurological manifestations. While degenerative dementia
is the commonest form of dementia, various metabolic, toxic, infective, and inflammatory …

[PDF][PDF] Page Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial …

A Agarwal, A Mukherjee, G Kumar, P Chatterjee… - researchgate.net
With few specific therapeutic options available to manage infection with Severe Acute
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), the novel coronavirus disease (COVID-19) …

Antibody binding to SARS-CoV-2 S glycoprotein correlates with, but does not predict neutralization (preprint)

S Ding, A Laumaea, R Gasser, H Medjahed… - 2020 - pesquisa.bvsalud.org
Convalescent plasma from SARS-CoV-2 infected individuals and monoclonal antibodies
were shown to potently neutralize viral and pseudoviral particles carrying the S glycoprotein. …

A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates (preprint)

A Vogel, I Kanevsky, Y Che, K Swanson, A Muik… - 2020 - pesquisa.bvsalud.org
To contain the coronavirus disease 2019 (COVID-19) pandemic, a safe and effective
vaccine against the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is …

Markers of Polyfunctional Sars-CoV-2 Antibodies in Convalescent Serum and Mucosa

H Natarajan - 2021 - search.proquest.com
SARS-CoV-2 is responsible for a global pandemic, resulting in over 2.5 million deaths
worldwide since late 2019. Understanding the immune response has played a critical role in the …

[HTML][HTML] In vitro study of BromAc on SARS-CoV-2 spike and envelope proteins shows synergy and disintegration at modest concentrations (preprint)

J Akhter, K Pillai, S Badar, A Mekkawy, S Valle… - 2020 - pesquisa.bvsalud.org
Objectives: SARS-CoV-2 infection is the cause of a worldwide pandemic, currently with
limited therapeutic options. It is characterised by being highly contagious and nasal mucosa …

Interaction of human ACE2 to membrane-bound SARS-CoV-1 and SARS-CoV-2 S glycoproteins (preprint)

SP Anand, Y Chen, J Prevost, R Gasser… - 2020 - pesquisa.bvsalud.org
A novel severe acute respiratory (SARS)-like coronavirus (SARS-CoV-2) is responsible for
the current global coronavirus disease 2019 (COVID-19) pandemic, infecting millions of …

UVA radiation could be a significant contributor to sunlight inactivation of SARS-CoV-2 (preprint)

P Luzzatto-Fegiz, F Temprano-Coleto, FJ Peaudecerf… - 2020 - pesquisa.bvsalud.org
Past experiments demonstrated SARS-CoV-2 inactivation by simulated sunlight; models have
considered exclusively mechanisms involving UVB acting directly on RNA. However, UVA …

Analysis of SARS-CoV-2 genomes from across Africa reveals potentially clinically relevant mutations.(preprint)

BC Iweriebor, OS Egbule, SO Danso, E Akujuru… - 2020 - pesquisa.bvsalud.org
SARS-CoV-2 is a betacoronavirus, the etiologic agent of the novel Coronavirus disease 2019
(COVID-19). In December 2019, an outbreak of COVID-19 began in Wuhan province of the …

JAMA Network Open Peer Reviewers in 2023

PR List - jamanetwork.com
JAMA Network Open Peer Reviewers in 2023 | JAMA Network Open | JAMA Network [Skip
to Navigation] Our website uses cookies to enhance your experience. By continuing to use …